• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,311.43 281.08
(0.56%)
Dow Jones
7,466.66 12.69
(0.17%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.70 0.18
(0.19%)
EUR-INR
112.25 0.09
(0.08%)
GBP-INR
129.69 0.32
(0.24%)
JPY-INR
0.61 0.00
(0.25%)

EQUITY - MARKET SCREENER

Vista Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524711
INE427C01021
7.2522662
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
45.24
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

GAIL (India) consolidated net profit declines 40.41% in the March 2026 quarter
May 22,2026
Net profit of GAIL (India) declined 40.41% to Rs 1484.72 crore in the quarter ended March 2026 as against Rs 2491.76 crore during the previous quarter ended March 2025. Sales declined 2.37% to Rs 35576.55 crore in the quarter ended March 2026 as against Rs 36440.29 crore during the previous quarter ended March 2025.

For the full year,net profit declined 39.10% to Rs 7582.47 crore in the year ended March 2026 as against Rs 12449.80 crore during the previous year ended March 2025. Sales declined 0.21% to Rs 141597.72 crore in the year ended March 2026 as against Rs 141901.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales35576.5536440.29 -2 141597.72141901.69 0
OPM %4.099.68 -8.1310.87 -
PBDT2439.934025.71 -39 13560.3117454.71 -22
PBT1966.373240.00 -39 9725.2213655.48 -29
NP1484.722491.76 -40 7582.4712449.80 -39